We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLY icon
601
John Wiley & Sons Class A
WLY
$2.85B
$1.29M 0.01%
22,462
+4,659
+26% +$252K
BLKB icon
602
Blackbaud
BLKB
$1.99B
$1.27M 0.01%
16,045
+2,817
+21% +$218K
ALV icon
603
Autoliv
ALV
$9.11B
$1.26M 0.01%
+12,220
New +$1.2M
COR icon
604
Cencora
COR
$62.2B
$1.26M 0.01%
9,506
-992
-9% -$122K
SWKS icon
605
Skyworks Solutions
SWKS
$9.33B
$1.25M 0.01%
8,054
-727
-8% -$116K
MFC icon
606
Manulife Financial
MFC
$73.5B
$1.24M 0.01%
64,854
+2,039
+3% +$39.5K
RVTY icon
607
Revvity
RVTY
$12.4B
$1.24M 0.01%
6,143
-21,010
-77% -$3.8M
STLD icon
608
Steel Dynamics
STLD
$36.7B
$1.22M 0.01%
19,682
LYV icon
609
Live Nation Entertainment
LYV
$42.2B
$1.22M 0.01%
10,179
-1,019
-9% -$110K
HES
610
DELISTED
Hess
HES
$1.2M 0.01%
16,265
-6,260
-28% -$508K
MRO
611
DELISTED
Marathon Oil Corporation
MRO
$1.2M 0.01%
73,309
-2,639
-3% -$42.4K
CM icon
612
Canadian Imperial Bank of Commerce
CM
$107B
$1.2M 0.01%
20,596
-1,076
-5% -$62.6K
NTAP icon
613
NetApp
NTAP
$34.2B
$1.19M 0.01%
12,887
DOC icon
614
Healthpeak Properties
DOC
$15.6B
$1.17M 0.01%
32,527
-12,561
-28% -$433K
PDD icon
615
Pinduoduo
PDD
$126B
$1.16M 0.01%
19,944
+3,795
+23% +$299K
SEER icon
616
Seer Inc
SEER
$115M
$1.14M 0.01%
50,000
+19,000
+61% +$548K
IP icon
617
International Paper
IP
$22.8B
$1.14M 0.01%
24,210
-1,465
-6% -$72.3K
WPC icon
618
W.P. Carey
WPC
$16.6B
$1.14M 0.01%
14,118
-1,418
-9% -$109K
ZEN
619
DELISTED
ZENDESK INC
ZEN
$1.12M 0.01%
+10,752
New +$1.15M
SFM icon
620
Sprouts Farmers Market
SFM
$7.49B
$1.11M 0.01%
37,396
-2,856
-7% -$71.5K
FMC icon
621
FMC
FMC
$1.3B
$1.09M 0.01%
9,967
-1,101
-10% -$111K
GDDY icon
622
GoDaddy
GDDY
$13.8B
$1.09M 0.01%
+12,867
New +$921K
PAYC icon
623
Paycom
PAYC
$7.96B
$1.09M 0.01%
2,630
-225
-8% -$107K
SUI icon
624
Sun Communities
SUI
$15.6B
$1.09M 0.01%
5,203
UA icon
625
Under Armour Class C
UA
$2.95B
$1.08M 0.01%
59,900
-5,711
-9% -$111K

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.